[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"primary-malignant-brain-tumor\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:primary-malignant-brain-tumor":26},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,1,0,[8],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":4,"eligibilityCriteria":15,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":4,"enrollmentInfo":18,"targetDuration":4,"studyType":21,"phases":22,"briefSummary":24,"conditions":25,"keywords":31,"overallStatus":33,"whyStopped":4,"lastUpdateSubmitDate":34,"lastUpdatePostDateStruct":35,"startDateStruct":38,"completionDateStruct":40,"leadSponsor":42,"locationsCount":5},"100592104","fearless-in-neurooncology-100592104",false,"NCT06989086","FearLess in NeuroOncology","FearLess in Neuro-Oncology","Inclusion Criteria:\n\nPatients:\n\n* Self-report a diagnosis of a primary malignant brain tumor (grade II-IV)\n* \\>2 weeks post-cranial resection or biopsy\n* Elevated Fear of Recurrence Distress Rating\n* Primarily English speaking\n* \\>\u002F= 18 years of age at the time of enrollment\n\nCaregivers:\n\n* nonprofessional caregiver to a patient with a primary malignant brain tumor (grade II-IV)\n* Elevated Fear of Recurrence Distress Rating\n* Primarily English speaking\n* \\>\u002F= 18 years of age at the time of enrollment\n\nExclusion Criteria:\n\nPatient \u002F Caregiver Exclusion:\n\n* Cognitive impairment that might prohibit active intervention engagement\n* Inability to understand and provide informed consent\n* Inability to attend virtual sessions due to unstable or no internet connection","ALL","18 Years",{"count":19,"type":20},112,"ESTIMATED","INTERVENTIONAL",[23],"NA","The overarching goal of this project is to assess the feasibility, acceptability, and appropriateness of recruitment methods, target population, and a waitlist design to finalize the protocol of FearLess in primary malignant brain tumor patients and caregivers",[26,27,28,29,30],"Primary Malignant Brain Tumor","Glioblastoma (GBM)","Astrocytoma","Oligodendroglioma","Caregiver",[32],"brain tumor","RECRUITING","2025-09-02",{"date":36,"type":37},"2025-09-09","ACTUAL",{"date":39,"type":37},"2025-06-24",{"date":41,"type":20},"2028-12-31",{"name":43,"class":44},"Virginia Commonwealth University","OTHER"]